1,274
Views
0
CrossRef citations to date
0
Altmetric
Obituary

In memory of Dr. Claudio Maurizio Pacella: a pioneer in clinical applications of image-guided laser ablation

ORCID Icon &
Pages 182-183 | Received 19 Jan 2020, Accepted 22 Jan 2020, Published online: 07 Feb 2020

References

  • Pacella CM, Papini E, Bizzarri G, et al. Hepatocellular carcinoma: magnetic resonance imaging after ultrasonically guided percutaneous alcohol treatment. Preliminary report. Ital J Gastroenterol. 1990;22(3):136–141.
  • Papini E, Panunzi C, Pacella CM, et al. Percutaneous ultrasound-guided ethanol injection: a new treatment of toxic autonomously functioning thyroid nodules? J Clin Endocrinol Metab. 1993;76(2):411–416.
  • Papini E, Pacella CM, Verde G. Percutaneous ethanol injection (PEI): what is its role in the treatment of benign thyroid nodules? Thyroid. 1995;5(2):147–150.
  • Pacella CM, Bizzarri G, Ferrari FS, et al. Interstitial photocoagulation with laser in the treatment of liver metastasis. Radiol Med. 1996;92(4):438–447.
  • Pacella CM, Bizzarri G, Guglielmi R, et al. Thyroid tissue: US-guided percutaneous interstitial laser ablation—a feasibility study. Radiology. 2000;217(3):673–677.
  • Pacella CM, Bizzarri G, Spiezia S, et al. Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology. 2004;232(1):272–280.
  • Sartori S, Mauri G, Tombesi P, et al. Ultrasound-guided percutaneous laser ablation is safe and effective in the treatment of small renal tumors in patients at increased bleeding risk. Int J Hyperth. 2018;35(1):1–7.
  • Di Matteo FM, Saccomandi P, Martino M, et al. Feasibility of EUS-guided Nd:YAG laser ablation of unresectable pancreatic adenocarcinoma. Gastrointest Endosc. 2018;88(1):168.e1–174.e1.
  • Pacella CM, Mauri G, Achille G, et al. Outcomes and risk factors for complications of laser ablation for thyroid nodules: a multicenter study on 1531 patients. J Clin Endocrinol Metab. 2015;100(10):3903–3910.
  • Pacella CM, Mauri G, Cesareo R, et al. A comparison of laser with radiofrequency ablation for the treatment of benign thyroid nodules: a propensity score matching analysis. Int J Hyperth. 2017;33(8):911–919.
  • Pacella CM, Bizzarri G, Magnolfi F, et al. Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. Radiology. 2001;221(3):712–720.
  • Mauri G, Cova L, Ierace T, et al. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol. 2016;39(7):1023–1030.
  • Patelli G, Ranieri A, Paganelli A, et al. Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Cardiovasc Intervent Radiol. 2017;40(9):1440–1446.
  • Pacella CM, Patelli G, Iapicca G, et al. Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study. Prostate Cancer Prostatic Dis. 2019. doi: 10.1038/s41391-019-0196-4.
  • Mauri G, Pacella CM, Papini E, et al. Proceedings of the first Italian conference on thyroid minimally invasive treatments and foundation of the Italian research group for thyroid minimally invasive procedures Int J Hyperth. 2018;34(5):603–605.
  • Mauri G, Pacella CM, Papini E, et al. Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid. 2019;29(5):611–618.
  • Papini E, Pacella CM, Solbiati LA, et al. Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group. Int J Hyperth. 2019;36:376–382.
  • Pacella CM, Jiang T, Mauri G. Image-guided laser ablation. Switzerland: Springer Nature Switzerland AG.